OXYGENTA PHARMACEUTICAL
|
The Current P/B Ratio of OXYGENTA PHARMACEUTICAL is -9.53.
| Share Price | ₹64.5 | Nov 07,2025 |
| Market Cap | ₹238.5 Cr | |
| Book Value | ₹-25.0 Cr | Mar2025 - Standalone Results |
| Price/Book | -9.53x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of OXYGENTA PHARMACEUTICAL
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹238.5 Cr] as on Nov 07,2025
(/) Book Value [ ₹-25.0 Cr] based on Mar2025 - Standalone Results
(=) P/B Ratio [ -9.53x ]
Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay '-9.53 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of OXYGENTA PHARMACEUTICAL !
The chart below summarizes the trend in P/B Ratio of OXYGENTA PHARMACEUTICAL over the last five years.
Historical PB (Price/Book ) ratio chart of OXYGENTA PHARMACEUTICAL
PB Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL
- OXYGENTA PHARMACEUTICAL 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged -3.71x.
- OXYGENTA PHARMACEUTICAL 's operated at median p/b ratio of -1.13x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/b ratio peaked in Mar2021 at 0x.
- OXYGENTA PHARMACEUTICAL 's p/b ratio hit its five-year low in Mar2025 of -11.76x.
How does OXYGENTA PHARMACEUTICAL 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| OXYGENTA PHARMACEUTICAL | -25.02 | -9.53 | 238.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.62 | 406,147.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.80 | 176,708.0 |
| CIPLA LTD | 31,079.30 | 3.91 | 121,525.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 15.96 | 121,147.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.01 | 100,596.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.54 | 93,419.6 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.96 | 94,968.4 |
| LUPIN LTD | 17,119.50 | 5.26 | 90,050.7 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.00 | 65,221.1 |
| ABBOTT INDIA LTD | 4,204.27 | 14.56 | 61,200.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs OXYGENTA PHARMACEUTICAL 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | -9.53x |
| Max industry PB | 15.96x |
| Median industry PB | 5.26x |
| Average industry PB | 5.74x |
You may also like the below Video Courses